Insmed Reports First Quarter 2019 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Insmed (INSM) Misses Q1 EPS by 1c
May 7, 2019 7:37 AM EDTInsmed (NASDAQ: INSM) reported Q1 EPS of ($0.96), $0.01 worse than the analyst estimate of ($0.95). Revenue for the quarter came in at $21.9 million versus the consensus estimate of $19.62 million.
The Company now expects full-year 2019 revenues for ARIKAYCE to be in the range of $90 million to $105... More
